NVCR Stock Summary and Trading Ideas (Novocure Limited - | NASDAQ:NVCR)

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

What symbol and exchange does Novocure Limited - shares trade?

Novocure Limited - trades on the NASDAQ stock market under the symbol NVCR.

What is Novocure Limited - stock price doing today?

As of May 1, 2026, NVCR stock price climbed to $16.62 with 3,398,565 million shares trading.

What is Novocure Limited -'s Beta?

NVCR has a beta of 1.45, meaning it tends to be more sensitive to market movements. NVCR has a correlation of 0.11 to the broad based SPY ETF.

How much is Novocure Limited - worth?

NVCR has a market cap of $1.92 billion. This is considered a Small Cap stock.

How much money does Novocure Limited - make?

Last quarter Novocure Limited - reported $174 million in Revenue and -$.62 earnings per share. This beat revenue expectation by $6 million and missed earnings estimates by -$.13.

What is the highest and lowest price Novocure Limited - traded in the last 3 year period?

In the last 3 years, NVCR traded as high as $83.60 and as low as $9.82.

What are the top ETFs holding Novocure Limited -?

The top ETF exchange traded funds that NVCR belongs to (by Net Assets): VTI, IWM, VB, VBK, VXF.

Is Novocure Limited - (NVCR) a good investment?

NVCR has underperformed the market in the last year with a return of -8.4%, while SPY returned +31.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NVCR shares. However, NVCR has outperformed the market in the last 3 month and 2 week periods, returning +34.0% and +31.7%, while SPY returned +4.4% and +2.7%, respectively. This indicates NVCR has been having a stronger performance recently.

What are the support and resistance levels for Novocure Limited - (NVCR)?

NVCR support price is $14.64 and resistance is $15.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVCR shares will trade within this expected range on the day.